ANEURYSMAL SUBARACHNOID HEMORRHAGE
Clinical trials for ANEURYSMAL SUBARACHNOID HEMORRHAGE explained in plain language.
Never miss a new study
Get alerted when new ANEURYSMAL SUBARACHNOID HEMORRHAGE trials appear
Sign up with your email to follow new studies for ANEURYSMAL SUBARACHNOID HEMORRHAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Spinal injection may prevent brain damage after aneurysm rupture
Disease control Recruiting nowThis study tests whether injecting the blood pressure drug nicardipine directly into the spinal fluid can improve recovery in people who develop dangerous blood vessel spasms after a brain aneurysm rupture. About 396 adults aged 18-80 who have had a brain aneurysm treated and a d…
Matched conditions: ANEURYSMAL SUBARACHNOID HEMORRHAGE
Phase: NA • Sponsor: The Affiliated Hospital Of Guizhou Medical University • Aim: Disease control
Last updated May 17, 2026 03:45 UTC
-
Could a single drug stop strokes after a brain bleed?
Disease control Recruiting nowThis early-stage study tests whether a drug called tocilizumab-aazg is safe for people who have had a burst brain aneurysm. The goal is to see if it can prevent strokes that sometimes happen after the initial bleed. About 30 adults will take part, and researchers will closely mon…
Matched conditions: ANEURYSMAL SUBARACHNOID HEMORRHAGE
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Could an Iron-Clearing drug improve outcomes after brain bleeding?
Disease control Recruiting nowThis study tests a drug called deferoxamine in people who have had a type of stroke caused by a brain aneurysm. The drug works by removing excess iron, which can cause further brain swelling and injury. About 120 participants will receive either the drug or a placebo, and their r…
Matched conditions: ANEURYSMAL SUBARACHNOID HEMORRHAGE
Phase: PHASE2 • Sponsor: Aditya S. Pandey, MD • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Could a common steroid help brain bleed survivors walk again?
Disease control Recruiting nowThis study tests whether a drug called fludrocortisone can help people recover better after a serious type of stroke caused by a brain aneurysm rupture. About 524 critically ill adults will receive either the drug or a placebo within 96 hours of their hospital admission. The main…
Matched conditions: ANEURYSMAL SUBARACHNOID HEMORRHAGE
Phase: PHASE2 • Sponsor: The George Institute • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Massive registry tracks brain aneurysm and stroke outcomes
Knowledge-focused Recruiting nowThis study is collecting information from 1,000 people who have been treated for brain aneurysms or stroke using MicroVention devices. The goal is to see how well these treatments work in everyday medical practice. No new treatments are being tested—just real-world data is gather…
Matched conditions: ANEURYSMAL SUBARACHNOID HEMORRHAGE
Sponsor: Microvention-Terumo, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 03:57 UTC
-
New coil strategy may prevent Re-Bleeding after severe stroke
Knowledge-focused Recruiting nowThis study looks at a new way to treat severe brain bleeds caused by aneurysms. Instead of coiling the whole aneurysm, doctors will only coil the dome (the bulging part). The goal is to see if this lowers the chance of another bleed. About 30 adults with severe bleeds will take p…
Matched conditions: ANEURYSMAL SUBARACHNOID HEMORRHAGE
Sponsor: University of Louisville • Aim: Knowledge-focused
Last updated May 17, 2026 03:54 UTC
-
Massive study digs into Body's clues after brain aneurysm
Knowledge-focused Recruiting nowThis study aims to understand why some people recover well after a brain aneurysm rupture while others face serious complications. Researchers will collect blood, spinal fluid, and other samples from 2000 patients to analyze their genes, proteins, and other molecules. The goal is…
Matched conditions: ANEURYSMAL SUBARACHNOID HEMORRHAGE
Sponsor: Xiaolin Chen, MD • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC